Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. | Ann Hematol | 2023 | 36790458 | PubTator, text mining | PubMed |
| Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. | Front Immunol | 2023 | 36776886 | PubTator, text mining | PubMed |
| Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report. | Diagn Cytopathol | 2023 | 36772934 | PubTator, text mining | PubMed |
| PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities. | Molecules | 2023 | 36770884 | PubTator, text mining | PubMed |
| BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. | Int J Mol Sci | 2023 | 36769189 | PubTator, text mining | PubMed |
| Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. | Int J Mol Sci | 2023 | 36768732 | PubTator, text mining | PubMed |
| The ATR Inhibitor VE-821 Enhances the Radiosensitivity and Suppresses DNA Repair Mechanisms of Human Chondrosarcoma Cells. | Int J Mol Sci | 2023 | 36768638 | PubTator, text mining | PubMed |
| Crystallization of VHL-based PROTAC-induced ternary complexes. | Methods Enzymol | 2023 | 36764760 | PubTator, text mining | PubMed |
| Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance. | J Pathol | 2023 | 36763038 | PubTator, text mining | PubMed |
| DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. | Cancer Res | 2023 | 36749655 | PubTator, text mining | PubMed |
| A two-faced selectivity solution to target SMARCA2 for cancer therapy. | Nat Commun | 2023 | 36720862 | PubTator, text mining | PubMed |
| RNA Polymerase II, the BAF remodeler and transcription factors synergize to evict nucleosomes. | bioRxiv | 2023 | 36711459 | PubTator, text mining | PubMed |
| Parental mosaicism detection and preimplantation genetic testing in families with multiple transmissions of de novo mutations. | J Med Genet | 2023 | 36707240 | PubTator, text mining | PubMed |
| Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators. | Asian J Androl | 2023 | 36695247 | PubTator, text mining | PubMed |
| Phthalates impact on the epigenetic factors contributed specifically by the father at fertilization. | Epigenetics Chromatin | 2023 | 36694265 | PubTator, text mining | PubMed |
| Inherited deletion of 9p22.3-p24.3 and duplication of 18p11.31-p11.32 associated with neurodevelopmental delay: Phenotypic matching of involved genes. | J Cell Mol Med | 2023 | 36691971 | PubTator, text mining | PubMed |
| Loss of the E3 ubiquitin ligases UBR-5 or HECD-1 restores Caenorhabditis elegans development in the absence of SWI/SNF function. | Proc Natl Acad Sci U S A | 2023 | 36689659 | PubTator, text mining | PubMed |
| Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs. | Pharmaceutics | 2023 | 36678785 | PubTator, text mining | PubMed |
| Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review. | Int J Mol Sci | 2023 | 36674511 | PubTator, text mining | PubMed |
| Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification. | Cancers (Basel) | 2023 | 36672415 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=26